Genprex
GNPX
19 hedge funds and large institutions have $6.28M invested in Genprex in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 3 closing their positions.
239% more call options, than puts
Call options by funds: $826K | Put options by funds: $244K
3% more capital invested
Capital invested by funds: $6.1M → $6.28M (+$179K)
0% less ownership
Funds ownership: 0% → 0% (-0%)
5% less funds holding
Funds holding: 20 → 19 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$140K |
| 2 |
Simplex Trading
Chicago,
Illinois
|
+$70K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Group One Trading
Chicago,
Illinois
|
-$70K |
| 2 |
SWM
Spire Wealth Management
Mclean,
Virginia
|
-$63K |
| 3 |
HighTower Advisors
Chicago,
Illinois
|
-$44K |
| 4 |
VF
Virtu Financial
New York
|
-$41K |
| 5 |
Goldman Sachs
New York
|
-$30K |
GNPX Hedge Fund Activity: Q3 2022 in Review
19 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Genprex (GNPX) for Q3 2022, worth a combined $6.28M — up 2.9% from $6.1M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of GNPX and 2 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $140K. The largest seller was Group One Trading, cutting an estimated $70K.
- 19 institutional investors held Genprex (GNPX) as of Q3 2022, down from 20 in Q2 2022.
- Funds reported $6.28M of Genprex stock for Q3 2022, up 2.9% quarter-over-quarter.
- 2 funds opened new Genprex positions in Q3 2022 and 3 closed out, a net change of -1 holder.
- The largest Genprex buyer in Q3 2022 was Renaissance Technologies, an estimated $140K added.
- The largest Genprex seller in Q3 2022 was Group One Trading, an estimated $70K sold.
Based on aggregated 13F filings for Q3 2022.